Celcuity Inc.
Organization details
- Legal name
- Celcuity Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Minneapolis
- Headquarters state / province
- Minnesota
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CELC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001603454
Board of directors
-
Brian F. Sullivan · Director · Chief Executive OfficerSince 2023
-
Charles R. Romp · DirectorSince 2026
-
David Dalvey · DirectorSince 2023
-
David W. Gryska · DirectorSince 2026
-
Lance G. Laing · Director · Chief Science OfficerSince 2023
-
Leo Furcht · DirectorSince 2023
-
Polly A. Murphy · DirectorSince 2023
-
Richard E. Buller · DirectorSince 2023
-
Richard Nigon · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 13, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
78.9%
-
91.7%
-
97.3%
-
97.4%
-
98.1%
-
98.8%
-
99.5%
Board connections
3 of this board's directors also sit on 3 other boards. 2 are in the same sector.
-
Atea Pharmaceuticals Inc. Same sectorvia Polly A. Murphy
-
Definium Therapeutics Inc. Same sectorvia David W. Gryska
- via Richard Nigon
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $327,564,880
- 17 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 7, 2026 | Leo Furcht Director | Option exercise | +250 | $7.60 | $1,900 |
| Oct 1, 2026 | David W. Gryska Director | Grant or award | +893 | — | — |
| Aug 14, 2026 | Brian F. Sullivan Director, Officer (Chief Executive Officer) | Grant or award | +80,000 | — | — |
| Aug 14, 2026 | Lance G. Laing Director, Officer (Chief Science Officer) | Grant or award | +20,000 | — | — |
| Aug 14, 2026 | Hahne Vicky Officer (Chief Financial Officer) | Grant or award | +16,000 | — | — |
| Jul 14, 2026 | Julian Baker Former 10% owner | Open-market sale | −261,368 | $102.50 | $26,790,220 |
| Jul 14, 2026 | Julian Baker Former 10% owner | Open-market sale | −2,838,632 | $102.50 | $290,959,780 |
| Jun 5, 2026 | Polly A. Murphy Director | Grant or award | +1,530 | — | — |
| Jun 5, 2026 | David Dalvey Director | Grant or award | +1,530 | — | — |
| Jun 5, 2026 | Charles R. Romp Director | Grant or award | +1,530 | — | — |
| Jun 5, 2026 | Richard Nigon Director | Grant or award | +1,530 | — | — |
| Jun 5, 2026 | Leo Furcht Director | Grant or award | +1,530 | — | — |
| Jun 5, 2026 | Richard E. Buller Director | Grant or award | +1,530 | — | — |
| Jun 2, 2026 | Lance G. Laing Director, Officer (Chief Science Officer) | Option exercise | +1,000 | $9.89 | $9,890 |
| May 19, 2026 | Richard E. Buller Director | Gift | −1,029 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Celcuity Inc.
Who is the CEO of Celcuity Inc.?
Brian F. Sullivan is Celcuity Inc.'s Chief Executive Officer.
How many directors are on Celcuity Inc.'s board?
Celcuity Inc.'s board has 9 directors: Brian F. Sullivan, Charles R. Romp, David Dalvey, David W. Gryska, Lance G. Laing, Leo Furcht, Polly A. Murphy, Richard E. Buller and Richard Nigon.
Are Celcuity Inc. insiders buying or selling shares?
Over the last 12 months, Celcuity Inc. insiders made no open-market purchases and sold $327.6 million of shares in 17 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="celcuity-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.